Eight Roads-backed PlasmaGen Bio snags funding, valuation nears $170 mn
Plasmagen Biosciences CEO Vivek Kamath PlasmaGen Biosciences, a biopharmaceutical company which counts investors such as Eight Roads Ventures…
Browsing Tag